Enzolytics Stock

Enzolytics CROIC

The Cash Return on Invested Capital (CROIC) of Enzolytics (ENZC) as of Aug 24, 2026 is 5.55 %.

CROIC

5.55 %

Last updated:

Cash Return on Invested Capital (CROIC) of Enzolytics is 2026 5.55 % . Cash Return on Invested Capital (CROIC) of Enzolytics was 2025 - . It decreases by % lower compared to the previous year.

The Enzolytics CROIC history

The Enzolytics CROIC history
YEARCROICYoY
5.55 %
Access this data via the Eulerpool API

Enzolytics Stock analysis

What does Enzolytics do? Enzolytics Inc is an innovative biotechnology company specializing in the development of effective therapies for combating infectious diseases and cancer. Enzolytics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enzolytics stock

Cash Return on Invested Capital (CROIC) of Enzolytics is 5.55 % in 2026.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Enzolytics since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Enzolytics with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

Profitability — Enzolytics

All Key Metrics — Enzolytics